Evaluation of microscopic tumor extension in non-small-cell lung cancer for three-dimensional conformal radiotherapy planning.

PURPOSE One of the most difficult steps of the three-dimensional conformal radiotherapy (3DCRT) is to define the clinical target volume (CTV) according to the degree of local microscopic extension (ME). In this study, we tried to quantify this ME in non-small-cell lung cancer (NSCLC). MATERIAL AND METHODS Seventy NSCLC surgical resection specimens for which the border between tumor and adjacent lung parenchyma were examined on routine sections. This border was identified with the naked eye, outlined with a marker pen, and the value of the local ME outside of this border was measured with an eyepiece micrometer. The pattern of histologic spread was also determined. RESULTS A total of 354 slides were examined, corresponding to 176 slides for adenocarcinoma (ADC) and 178 slides for squamous cell carcinoma (SCC). The mean value of ME was 2.69 mm for ADC and 1.48 mm for SCC (p = 0.01). The usual 5-mm margin covers 80% of the ME for ADC and 91% for SCC. To take into account 95% of the ME, a margin of 8 mm and 6 mm must be chosen for ADC and SCC, respectively. Aerogenous dissemination was the most frequent pattern observed for all groups, followed by lymphatic invasion for ADC and interstitial extension for SCC. CONCLUSION The ME was different between ADC and SCC. The usual CTV margin of 5 mm appears inadequate to cover the ME for either group, and it must be increased to 8 mm and 6 mm for ADC and SCC, respectively, to cover 95% of the ME. This approach is obviously integrated into the overall 3DCRT procedure and with other margins.

[1]  R. Abratt.  Dose-effect relationships for functional local injury after lung irradiation. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  K. Nagashima,et al.  Prognostic significance of an interface pattern of central fibrosis and tumor cells in peripheral adenocarcinoma of the lung. , 1995, Human pathology.

[3]  P. Köpf-Maier,et al.  The basement membrane and its involvement in carcinoma cell invasion. , 1995, Acta anatomica.

[4]  Douglas L. Jones.  ICRU Report 50—Prescribing, Recording and Reporting Photon Beam Therapy , 1994 .

[5]  Pathology of the Lung , 1964 .

[6]  G J Kutcher,et al.  Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer. , 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

[7]  D. Carbone.  The biology of lung cancer. , 1997 .

[8]  H. Soeda,et al.  New Classification of Small Pulmonary Nodules by Margin Characteristics on Highresolution CT , 1999, Acta radiologica.

[9]  R Mohan,et al.  The biological basis for conformal three-dimensional radiation therapy. , 1991, International journal of radiation oncology, biology, physics.

[10]  J. Armstrong.  Target volume definition for three-dimensional conformal radiation therapy of lung cancer. , 1998, The British journal of radiology.

[11]  M. Ohkawa,et al.  CT-pathologic correlation in the tumor margins of lung cancer. , 1996, Radiation medicine.

[12]  H. Enterline,et al.  The prognostic implications of vascular invasion in primary carcinomas of the lung; a clinicopathologic correlation of two hundred twenty-five cases with one hundred per cent follow-up. , 1958, A.M.A. archives of pathology.

[13]  R. Weller,et al.  International Histological Classification of Tumours , 1981 .

[14]  C. Ling,et al.  3-D conformal radiation therapy for non-small cell lung carcinoma. Clinical experience at the Memorial Sloan-Kettering Cancer Center. , 1996, Frontiers of radiation therapy and oncology.

[15]  Michael Goitein,et al.  Nonstandard deviations: Communications , 1983 .

[16]  K. Hiroshima,et al.  Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases , 1995, Cancer.

[17]  J A Purdy,et al.  Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC) , 1999, International journal of radiation oncology, biology, physics.

[18]  D. Tarin,et al.  Recent advances in the study of tumour invasion and metastasis. , 1994, Journal of clinical pathology.

[19]  M. Martel,et al.  Dose escalation for non-small cell lung cancer using conformal radiation therapy. , 1997, International journal of radiation oncology, biology, physics.

[20]  R. Coleman,et al.  Applications of PET in lung cancer. , 1998, Seminars in nuclear medicine.

[21]  M Goitein,et al.  Strategies for treating possible tumor extension: some theoretical considerations. , 1985, International journal of radiation oncology, biology, physics.

[22]  P. Tracqui.  From passive diffusion to active cellular migration in mathematical models of tumour invasion , 1995, Acta biotheoretica.

[23]  H S Glazer,et al.  Three-dimensional radiation treatment planning study for patients with carcinoma of the lung. , 1994, International journal of radiation oncology, biology, physics.

[24]  P Aaltonen,et al.  Specification of dose delivery in radiation therapy , 1997 .

[25]  J A Antolak,et al.  Planning target volumes for radiotherapy: how much margin is needed? , 1999, International journal of radiation oncology, biology, physics.

[26]  R. Drury.  Pathology of the Lung: 4th edn , 1986 .

[27]  C. Edwards.  Pulmonary adenocarcinoma: review of 106 cases and proposed new classification. , 1987, Journal of clinical pathology.

[28]  J. Sudbø,et al.  The invasive front of carcinomas. The most important area for tumour prognosis? , 1998, Anticancer research.

[29]  P Aaltonen,et al.  Specification of dose delivery in radiation therapy. Recommendation by the Nordic Association of Clinical Physics (NACP). , 1997, Acta oncologica.

[30]  R K Ten Haken,et al.  Dose-volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. , 1994, International journal of radiation oncology, biology, physics.

[31]  Emami.  Three-Dimensional Conformal Radiation Therapy In Bronchogenic Carcinoma. , 1996, Seminars in radiation oncology.

[32]  Harlan I. Firminger,et al.  Atlas of tumor pathology , 1954 .

[33]  J. Purdy,et al.  Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. , 1995, International journal of radiation oncology, biology, physics.

[34]  T. Landberg,et al.  What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  R. Welsh,et al.  Prognostic factors in T1 NO MO adenocarcinomas and bronchioloalveolar carcinomas of the lung. , 1999, American journal of clinical pathology.

[36]  S. Jiang,et al.  Tumor extension and cell proliferation in adenocarcinomas of the lung. , 1999, The American journal of pathology.

[37]  A. Liebow.  Tumors of the lower respiratory tract , 1952 .

[38]  R Mohan,et al.  Intensity modulation optimization, lateral transport of radiation, and margins. , 1996, Medical physics.

[39]  Y. Shimosato,et al.  Histological Typing of Lung and Pleural Tumours , 1999, World Health Organization.

[40]  L. S. Broderick,et al.  Imaging of lung cancer: old and new. , 1997, Seminars in oncology.

[41]  D. Whittlesey,et al.  Prospective computed tomographic scanning in the staging of bronchogenic cancer. , 1988, The Journal of thoracic and cardiovascular surgery.